Last reviewed · How we verify

NCT07045818

DLPFC and Sympathetic Reactivity in RPL With Anxiety

Recruiting now Last updated 18 November 2025
What this trial tests

trial testing Emotional provocation task involving multisensory aversive stimuli in Recurrent Pregnancy Loss Without Current Pregnancy in 50 participants. Currently enrolling.

Timeline
1 July 2025
Primary endpoint
30 March 2026
31 March 2026

Quick facts

Lead sponsorShenyang Medical College
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 July 2025
Primary completion30 March 2026
Estimated completion31 March 2026
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Shenyang Medical College

Who can join

Adults 18 to 45, female only, with Recurrent Pregnancy Loss Without Current Pregnancy or Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We propose an exploratory clinical study (NEURO-CARD-2) that employs simultaneous functional near-infrared spectroscopy (fNIRS) and electrocardiography (ECG) to investigate interhemispheric dysfunction in the dorsolateral prefrontal cortex (DLPFC) and its relationship with autonomic sympathetic activation in women with recurrent pregnancy loss (RPL) and comorbid anxiety. Using a standardized multisensory aversive emotional stimulation paradigm, the study will assess cortical and cardiac responses within the framework of the Brain-Heart-Emotion interaction model. The objective is to identify neurobiological signatures underlying emotion-autonomic dysregulation in this population, thereby informing future development of precision-targeted interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Shenyang Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07045818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing